19th November 2019 – The hormone
replacement therapy (HRT) market is estimated to grow at a CAGR of 8.2%
during the forecast period. Hormone replacement therapy (HRT) is basically used
for middle- age females to cure certain symptoms post-menopause. The treatment
successfully replaces the hormones so that patient’s body turns slightly
incapable to produce any hormone due to its age, early failure of reproductive
organs. The treatment is given to women and in some cases, HRT is available for
males too.
Hormone replacement therapy market is
highly driven by factors such as rise in technological advancements in drug
delivery systems and rise in awareness among patients. Subsequently, rise in
young female population with menopausal issues and PCOD is likely to contribute
to the market growth in the forecast period.
Get
a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/hormone-replacement-therapy-hrt-market/request-sample
Disease type segment for hormone
replacement therapy (HRT) market includes growth hormone deficiency, menopause,
male hypogonadism and hypothyroidism. Hypogonadism type is expected grow owing
to change in lifestyle since it is a lifestyle related disease. Menopause based
hormone replacement is anticipated to rise at a staggering CAGR in the
forthcoming period due to presence of generic drugs and availability of various
brands and rise in awareness among women.
Geographical segmentation for hormone
replacement therapy (HRT) industry spans North America, South America, Europe,
Asia-Pacific, Middle East and Africa. North American region is the most
lucrative market owing to rise in cases of lifestyle related disease coupled
with rise in chronic ailments.
Asia-Pacific regions are likely to gain
a significant growth in the forecast period due to rise in awareness levels of
end users and improvement in healthcare infrastructure. Rise in young female
population coupled with increase in workload stress is likely to boost the
market during the forecast period. The key players in the hormone replacement
therapy market include Pfizer, Novo Nordisk, Merck Serono, Bayer Healthcare,
Novartis, Eli Lilly, Mylan Laboratories, Roche and Genentech.
Get
in touch
At Million Insights, we work with the
aim to reach the highest levels of customer satisfaction. Our representatives
strive to understand diverse client requirements and cater to the same with the
most innovative and functional solutions.
For
More Information, Visit @ https://www.millioninsights.com
No comments:
Post a Comment